Decreased efficacy of a COVID-19 vaccine due to mutations present in early SARS-CoV-2 variants of concern

With the SARS-CoV-2 virus still circulating and evolving, there remains an outstanding question if variant-specific vaccines represent the optimal path forward, or if other strategies might be more efficacious towards providing broad protection against emerging variants. Here, we examine the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Weidenbacher, Payton A.-B., Friedland, Natalia, Sanyal, Mrinmoy, Morris, Mary Kate, Do, Jonathan, Hanson, Carl, Kim, Peter S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326996/
https://www.ncbi.nlm.nih.gov/pubmed/37425802
http://dx.doi.org/10.1101/2023.06.27.546764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326996/
https://www.ncbi.nlm.nih.gov/pubmed/37425802
http://dx.doi.org/10.1101/2023.06.27.546764

Ejemplares similares